Suven Pharmaceuticals acquires majority stake in NJ Bio, strengthens US presence

Suven Pharmaceuticals Limited, a technology-focused contract development and manufacturing organisation (CDMO), has announced the acquisition of a controlling 56% stake in NJ Bio Inc., a ... Read More